Atezolizumab

Atezolizumab is a type of monoclonal antibody. It works by blocking the activity of a protein located on the T cells- a type of white blood cells that regulate the functioning of the immune system. In the presence of Atezolizumab, the killing power of T-cells is restored and the immune response is stimulated to locate and destroy cancer cells.

Fatigue, Cough, Breathlessness, Decreased appetite, Urinary tract infection, Infusion site reaction, Decreased level of thyroid hormones, Hyperthyroidism, Low blood platelets, Decreased potassium level in blood, Decreased sodium level in blood, Increased glucose level in blood, Hypotension (low blood pressure), Headache, Increased aspartate aminotransferase, Increased alanine aminotransferase, Hepatitis (viral infection of liver), Gastrointestinal disturbance, Colitis, Abdominal pain, Voice change, Oropharyngeal pain, Rash, Itching, Dry skin, Joint pain, Back pain, Musculoskeletal (bone, muscle or joint) pain, Increased creatinine level in blood, Weakness, Flu-like symptoms, Pancreatic inflammation, Severe cutaneous adverse reactions, Myositis, Psoriasis, Adrenal insufficiency, Hypopituitarism, Diabetes, Nephritis, Guillain-Barré syndrome, Meningoencephalitis, Hypophysitis, Uveitis, Myocarditis (inflammation of heart muscle)